Screen readers: Two navigational links to follow.Skip to site navigation.Skip to page content.
The University of Iowa News Services
The University of Iowa News Services Home News Releases UI in the News Subscribe to UI News Contact Us

University of Iowa News Release


Jan. 31, 2008

Wells leads College of Pharmacy Division of Pharmaceutical Service

Mickey Wells, Ph.D., has been named director of the University of Iowa College of Pharmacy's Division of Pharmaceutical Service.

Wells, whose appointment was effective Jan. 8, succeeds Rolland Poust, Ph.D., who has served as director of the division since 1991. Poust remains at the college as professor and interim head of the Division of Pharmaceutics.

Wells comes to the UI from GlaxoSmithKline Inc., the multinational, research-based pharmaceutical company with operations based in the United States. He comes to the UI with more than 17 years experience in pharmaceutical development. Since 2005, Wells had served as manager of strategic technologies at the company's facilities in Research Triangle Park, N.C. He has served in other capacities, as well, including manager of product development and senior research investigator.

While at GlaxoSmithKline, Wells played a key role in the development of pharmaceutical products such as Wellbutrin (bupropion), an antidepressant also used in smoking cessation treatments; Zantac (ranitidine), a treatment for gastroesophageal reflux disease; and Epivir (lamivudine), a medication used to treat HIV and AIDS. Wells is listed as co-inventor on a number of patent applications related to drug composition, and throughout his career he has published journal articles and book chapters and participated in professional service activities through the American Association of Pharmaceutical Scientists.

"We are extremely pleased to have Dr. Mickey Wells join the college and spearhead our internationally recognized pharmaceutical services program," said Donald Letendre, dean of the UI College of Pharmacy. "Mickey brings to the university a wealth of experience from his years in the corporate pharmaceutical manufacturing sector and long-standing commitment to the development of high quality pharmaceuticals."

Letendre also had words of praise for Poust. "Dr. Poust has done a tremendous job for the past 17 years as director of the Division of Pharmaceutical Service. Under his leadership, the division has continued to strengthen its position in pharmaceutical manufacturing and maintain its outstanding reputation for high quality product development."

An Iowa native from Sheffield, Wells received an Associate of Science degree (1984) from the North Iowa Area Community College (NIACC) in Mason City. He went on to receive both a bachelor's degree (1987) and a doctorate in pharmaceutics (1990) at the UI College of Pharmacy. In addition to his new role as director of Pharmaceutical Service, Wells will have an academic appointment as an associate professor in the Division of Pharmaceutics.

The college's Division of Pharmaceutical Service is the most experienced university-affiliated drug manufacturing facility registered with the U.S. Food and Drug Administration and has been producing clinical supplies in compliance with Good Manufacturing Practices since 1974. Pharmaceutical firms from around the world use the manufacturing facility to produce supplies of new pharmaceutical agents for use in clinical trials. For more information, visit

STORY SOURCE: University of Iowa Health Science Relations, 5139 Westlawn, Iowa City, Iowa 52242-1178

MEDIA CONTACT: David Pedersen, 319-335-8032,